This is one of the biggest peptide regulatory shifts in years. And it's just getting started. The FDA has taken its first step toward reversing its 2023 stance, removing 12 peptides from Peptides! Update as of 4.15.26 from the FDA. We will know more in July. This will allow these previously labeled category 2 research peptides to category 1 and allowable for compounding by Is BPC 157 Banned? Oral vs. Injectable Forms Explained BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved BPC 157: A MAHA Adjacent Peptide, Linked to Croatia